CIAM
IMA

Caitong International Asset Management’s ImageneBio Inc IMA Stock Holding History

Caitong International Asset Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10 Buy
+2
New +$13 ﹤0.01% 2146

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caitong International Asset Management's IMA Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in ImageneBio Inc (IMA) in Q1 2026: 2 shares worth $10. The stake represents ﹤0.01% of the portfolio and ranks #2146 among its holdings.

39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Caitong International Asset Management held 2 shares of ImageneBio Inc worth $10 as of Q1 2026.
  • ImageneBio Inc was a new Caitong International Asset Management position in Q1 2026.
  • ImageneBio Inc made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2146 holding.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.